ResearcherDalian University of TechnologyActive in the last 2 years
Jing Li Huang
Matched on ORCID iD 0000-0002-7163-5156; OpenAlex author ID A5044954997. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 5
- Prognostic value of miR-21 in colorectal cancer, pancreatic ductal adenocarcinoma, and esophageal squamous cell carcinoma: updated systematic review and meta-a… Co-author DOI 10.1093/oncolo/oyaf309↗
- Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study. Co-author DOI 10.1007/s10620-024-08338-4↗
- Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer. First author DOI 10.1016/j.isci.2024.110027↗
- Advance in microRNA as a potential biomarker for early detection of pancreatic cancer. Co-author DOI 10.1186/s40364-016-0074-3↗
- Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Co-author DOI 10.1016/j.celrep.2014.03.061↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianzhou Liu · 3 shared papers, 2016–2024 · strength 0.43
- Paper Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer. DOI 10.1016/j.isci.2024.110027↗
- Paper Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study. DOI 10.1007/s10620-024-08338-4↗
- Paper Advance in microRNA as a potential biomarker for early detection of pancreatic cancer. DOI 10.1186/s40364-016-0074-3↗
- Vay Liang W. Go · 3 shared papers, 2016–2024 · strength 0.43
- Paper Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer. DOI 10.1016/j.isci.2024.110027↗
- Paper Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study. DOI 10.1007/s10620-024-08338-4↗
- Paper Advance in microRNA as a potential biomarker for early detection of pancreatic cancer. DOI 10.1186/s40364-016-0074-3↗
- Gary Guishan Xiao · 3 shared papers, 2016–2024 · strength 0.43
- Paper Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer. DOI 10.1016/j.isci.2024.110027↗
- Paper Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study. DOI 10.1007/s10620-024-08338-4↗
- Paper Advance in microRNA as a potential biomarker for early detection of pancreatic cancer. DOI 10.1186/s40364-016-0074-3↗
- Chunbao Zhai · 1 shared paper, 2025 · strength 0.37
- Qiang He · 1 shared paper, 2025 · strength 0.37
- Junchao Guo · 2 shared papers, 2024 · strength 0.36
- Wenchao Xu · 1 shared paper, 2024 · strength 0.20
- Dong Shang · 1 shared paper, 2024 · strength 0.20
- Zhigang Zhang · 1 shared paper, 2024 · strength 0.16
- Yefu Liu · 1 shared paper, 2024 · strength 0.16
- Yongwei Sun · 1 shared paper, 2024 · strength 0.16
- Minwei Yang · 1 shared paper, 2024 · strength 0.16
- Dong Shang · 1 shared paper, 2024 · strength 0.16
- Ge Gao · 1 shared paper, 2024 · strength 0.16
- Hartmut Land · 1 shared paper, 2014 · strength 0.04
- Aram F. Hezel · 1 shared paper, 2014 · strength 0.04
- Conan Kinsey · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.